Schrodinger, Inc.

SDGR Healthcare Health Information Services

Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024. In the quarter to June 2026, revenue grew 7.54%, EPS grew 113.6% and free cash flow grew 34.4%, each against the same quarter a year earlier.

22.60 2.88 −11.30%
Market cap
$1.9B
P/E
0.0×
Fwd P/E
−7.1×
Dividend yield
—
F-score
5/9
Altman Z
1.10
Beneish M
−3.47
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cash and Short Term Investments
402.33 367.46 468.75 456.33 579.48 643.19 86.33 84.07 36.34
Receivables
104.39 255.33 89.12 69.09 40.55 35.38 25.74 18.02 9.76
Other current assets
— — — — — — — — 1.95
Total current assets
519.27 634.99 567.80 533.99 625.06 682.98 118.54 104.69 48.05
Property, Plant, Equpment (Net)
19.46 24.20 23.33 14.24 10.03 5.14 6.27 7.97 5.44
Long-Term Investments
73.65 43.21 83.25 25.68 43.17 45.66 15.37 5.44 2.61
Goodwill and Intangible Assets (Total)
4.79 4.79 4.79 5.38 — — — 0.02 0.05
Long-term assets (Other)
6.27 4.16 6.01 3.31 2.85 2.35 2.34 2.63 1.87
Total non-current assets
206.90 188.23 235.16 154.60 131.43 63.29 36.73 16.04 —
Total Assets
726.16 823.23 802.96 688.59 756.49 746.26 155.27 120.73 —
Accounts Payable
11.45 10.67 16.82 9.47 8.08 8.40 3.52 2.77 1.61
Accrued Expenses
39.26 42.11 31.76 24.88 18.41 12.00 7.03 4.09 —
Current Revenue (Deferred)
112.85 111.94 56.23 57.93 55.37 45.40 25.05 17.62 —
Other current liabilities
— — — — — — — — 16.21
Total current liabilities
189.14 191.75 133.67 108.80 91.21 73.21 45.02 27.01 17.82
Non-current Revenue (Deferred)
78.88 108.81 9.04 25.60 30.06 41.16 2.21 3.60 2.78
Non-current Liabilities (Other)
1.28 0.15 0.67 0.80 0.30 0.65 0.90 0.49 0.48
Total non-current liabilities
172.97 210.03 120.72 131.88 108.19 49.04 11.99 3.60 —
Total liabilities
362.11 401.78 254.40 240.68 199.40 122.24 57.01 30.60 21.07
Additional Paid In Capital
992.02 946.04 885.97 828.70 786.96 752.56 11.66 8.92 —
Preferred Stock (Total)
— — — — — — 191.58 161.69 —
Common Stock (Net)
0.74 0.73 0.72 0.71 0.71 0.70 0.06 0.06 0.41
Retained Earnings
(628.81) (525.54) (338.42) (379.14) (229.95) (129.56) (105.10) (80.52) (52.10)
Common Equity (Total)
364.05 421.45 548.56 447.91 557.09 624.02 (93.32) (71.56) (45.36)
Shareholders Equity (Total)
364.05 421.45 548.56 447.91 557.09 624.02 98.26 90.13 36.95
Shareholders Equity and Liabilities (Total)
726.16 823.23 802.96 688.59 756.49 746.26 155.27 120.73 —
Shares (Common)
73.68 72.87 72.14 71.33 71.00 69.88 6.12 5.91 —
Shares (Preferred)
— — — — — — 324.75 324.75 —
Shareholders Equity (Tangible)
359.26 416.65 543.77 442.53 557.09 624.02 98.26 90.13 —
Net Debt
(402.33) (367.45) (468.75) (456.33) (579.48) (643.19) (86.33) (84.07) (36.34)
Total Debt
— — — 116.49 79.87 11.76 206.05 — —

Fold the line items

In millions of $ except per-share values · columns are period end dates